Cargando…
CD4+ T Cells Specific for C. difficile Toxins are a Marker of Patients with Active Relapsing Disease
BACKGROUND: The bacterial pathogen Clostridium difficile is the leading cause of nosocomial infectious diarrhea. Although C. difficile infection (CDI) can be treated with antibiotics, approximately 25% of patients relapse after treatment. The pathogenicity of CDI requires the activities of its toxin...
Autores principales: | Cook, Laura, Wong, May, Rees, William, Lau, Torey, Levings, Megan, Steiner, Theodore |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630914/ http://dx.doi.org/10.1093/ofid/ofx163.948 |
Ejemplares similares
-
493. Development of a Simple Clostridium difficile Infection Clinical Risk Prediction Tool for Medical Inpatients
por: Ma, Winnie, et al.
Publicado: (2018) -
Analysis of Flagellin-Specific Adaptive Immunity Reveals Links to Dysbiosis in Patients With Inflammatory Bowel Disease
por: Cook, Laura, et al.
Publicado: (2019) -
839. Effect of Clostridioides difficile (C. difficile) Toxin Test Reporting on Clinical Treatment and Outcomes of Toxin-Negative PCR-Positive Patients at Five California Hospitals
por: Polage, Christopher R, et al.
Publicado: (2019) -
T-Cell Specificity Matters in IBD: Impaired IL10 Production Revealed by OmpC-Tetramers
por: Cook, Laura, et al.
Publicado: (2020) -
2366. PCR Followed by Toxin EIA for the Diagnosis of C. difficile Infection
por: Zhang, Yu, et al.
Publicado: (2019)